Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.74M Buy
273,490
+2,396
+0.9% +$42.6K 0.01% 486
2026
Q2
$4.41M Sell
271,094
-32,567
-11% -$581K 0.01% 523
2026
Q1
$5.78M Buy
303,661
+132,225
+77% +$2.56M 0.01% 446
2025
Q4
$2.81M Buy
171,436
+46,651
+37% +$821K 0.01% 558
2025
Q3
$2.34M Hold
124,785
– – 0.01% 566
2025
Q2
$2.52M Buy
124,785
+17,599
+16% +$304K 0.01% 548
2025
Q1
$1.47M Hold
107,186
– – ﹤0.01% 634
2024
Q4
$1.27M Buy
107,186
+16,624
+18% +$262K ﹤0.01% 742
2024
Q3
$1.62M Buy
+90,562
New +$1.65M ﹤0.01% 638

Other funds holding XP

KBC Group's XP Position: Q3 2026 in Review

KBC Group increased its XP (XP) stake by 0.88% in Q3 2026, buying an estimated $42.6K and bringing the position to 273,490 shares worth $5.74M. The position accounts for 0.01% of the portfolio, ranked #486.

KBC Group first reported a position in XP in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.78M in Q1 2026. 252 funds tracked by Wall St. Rank hold XP as of Q3 2026.

  • KBC Group held 273,490 shares of XP worth $5.74M as of Q3 2026.
  • KBC Group bought 2,396 XP shares in Q3 2026, an estimated $42.6K.
  • XP made up 0.01% of KBC Group's portfolio in Q3 2026, its #486 holding.
  • KBC Group first reported a position in XP in Q3 2024 and has held it in 9 quarters since.
  • KBC Group's XP position peaked at $5.78M in Q1 2026.
  • 252 funds tracked by Wall St. Rank held XP as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.